STUDY QUESTION: Do adipose tissue-derived stem cells (ASCs) enhance vascularization and follicle survival in xenografted ovarian tissue using a two-step transplantation approach?
Introduction
Ovarian tissue cryopreservation and transplantation for fertility preservation and restoration purposes is one of the only available options for young women who need to undergo immediate treatment for cancer or certain benign diseases, and the only alternative for prepubertal girls (Jadoul et al., 2010) . However effective they may be as treatments for the underlying pathology, chemotherapy and radiotherapy are known to be highly gonadotoxic, often leading to premature ovarian failure and subsequent infertility (Wallace et al., 2005) . Since cancer survival rates have been steadily increasing over the last couple of decades, so has the clinical application of ovarian tissue transplantation, designed to offer young women the chance of bearing children of their own (Donnez and Dolmans, 2017) .
There is now enough evidence to support the feasibility and efficacy of ovarian tissue cryopreservation and transplantation for both fertility preservation and restoration Donnez and Dolmans, 2017) . Nevertheless, although more than 130 live births have been reported worldwide using this approach (Donnez and Dolmans, 2017) , there are still a number of issues to address regarding the grafting procedure, because transplanted tissue undergoes massive follicle loss in the early post-grafting period (Baird et al., 1999; Kim, 2006) . As described in animal models, since ovarian tissue is transplanted without vascular anastomosis, the graft goes through a period of hypoxia and ischemia that lasts 3-5 days before progressive revascularization (Van Eyck et al., 2009) . It typically shows functional vessels from Day 7 onwards (Israely et al., 2004) .
A number of attempts have been made to resolve the problem of hypoxic conditions and their consequences encountered in the early post-grafting period, and hence the efficacy of ovarian tissue transplantation. Xenografting models (Friedman et al., 2012; Mahmoodi et al., 2014 Mahmoodi et al., , 2015 Zhang et al., 2015) have investigated treatments with vascular endothelial growth factor (VEGF), N-acetyl cysteine, erythropoietin, vitamin E and melatonin, among others. However, no significant clinically translatable improvement has been observed so far.
More recent approaches include use of mesenchymal stem cells (MSCs) derived from different sources in the context of ovarian tissue transplantation, taking advantage of their proangiogenic, antiapoptotic and immunomodulatory properties (Damous et al., 2015; Xia et al., 2015) . Adipose tissue-derived stem cells (ASCs), an easily obtainable source of autologous MSCs, constitute a population of stem cells with proven multilineage differentiation potential (Zuk et al., 2002) .
In a recent publication, we have demonstrated that high concentrations of ASCs delivered inside a fibrin implant used to prepare the ovarian tissue transplantation site 14 days prior to grafting achieved better vascularization (Manavella et al., 2018) . The goal of this study was to apply our previous protocol to test the short-term effects of a novel two-step ovarian tissue transplantation approach using ASCs, aiming to increase follicle survival rates through improved graft vascularization.
Materials and Methods

Experimental design
A total of 15 severe combined immunodeficient (SCID) mice were intraperitoneally grafted with frozen-thawed human ovarian tissue (OT) from five different patients. A peritoneal transplantation site had been previously prepared in a first step using either empty fibrin (Fi+OT group [n = 5]) or ASC-loaded fibrin (Fi/ASCs+OT group [n = 5]) for 14 days prior to ovarian tissue grafting. Five mice were grafted using the standard one-step transplantation procedure and served as controls (OT group) (Fig. 1) . Lithium phthalocyanine (LiPc) crystals were inserted into all grafted human ovarian tissue before transplantation as previously described (Van Eyck et al. 2009 ). One piece of ovarian tissue per patient was fixed for analysis to serve as non-grafted controls.
Levels of partial pressure of oxygen (pO 2 ) were monitored in vivo by electron paramagnetic resonance (EPR) oximetry on post-grafting Days 3 (n = 15) and 7 (n = 15). Samples were collected after euthanizing the mice on Day 7 following EPR.
Adipose tissue-derived stem cells
Previously characterized human ASCs from female donors were commercially acquired (Stempro ® human ASCs, Invitrogen, USA). They were cultured and passaged as previously described (Manavella et al., 2018) (Supplementary materials and methods). All cells used in this study were between passages 4 and 8.
Ethical approval
Animal welfare guidelines were followed and the protocol was approved by the Committee on Animal Research of the Université Catholique de Louvain.
Step 1: Preparation of the peritoneal ovarian tissue transplantation site A recently established protocol was used to select ASCs concentrations and the fibrin implant reconstitution procedure (Manavella et al., 2018) (Supplementary materials and methods).
Ten 7-10-week-old SCID mice (Charles River Laboratories, France) were used for this part of the study (Fig. 1) . After intraperitoneal injection of 0.07 mL Imalgene 500 (Rhône Merieux, Belgium) and 0.16 mL Rompun 2% (diluted ×100, Bayer, Belgium) , a horizontal incision was made in the skin and abdominal wall to attach the implants to the lower third of the parietal peritoneum to avoid bowel movements during EPR measurement. The inner peritoneal surface was scratched with a scalpel (Luyckx et al., 2014) , before gently suturing the implant with 2 or 3 cardinal stitches using 7/0 Prolene ( Fig. 2A) . Five mice were grafted with an empty fibrin scaffold (Fi+OT group) and five with a scaffold containing 1.5 × 10 6 ASCs (Fi/ASCs+OT group). The abdominal wall and skin were then closed with 6/0 Prolene.
Step 2: Ovarian tissue transplantation
Human ovarian tissue thawing procedure
The Institutional Review Board of the Université Catholique de Louvain approved use of human ovarian tissue for this study. Frozen ovarian tissue biopsies were taken from five women (aged 25-35 years) undergoing surgery for non-ovarian pathologies, who gave written informed consent to donate their cryopreserved ovarian tissue for research purposes. Frozen ovarian tissue was thawed at room temperature for 2 min, immersed in a water bath at 37°C for another 2 min, and then washed three times with fresh HEPES-MEM medium (Gibco) to remove the cryoprotectant .
LiPc crystal insertion and ovarian tissue transplantation
Four ovarian tissue fragments measuring~5 × 4 × 1 mm 3 from each patient were thawed and distributed equally between four different study groups; one fragment was immediately fixed (non-grafted control), two fragments were used for the two-step transplantation procedure (Fi+OT and Fi/ASCs+OT groups), and one fragment was grafted following the standard one-step protocol (OT group). Two to three LiPc crystals (Dartmouth Medical School, USA) were inserted into the ovarian tissue fragments, as previously described (Van Eyck et al., 2009) (Fig. 2B) , before proceeding to transplantation.
In the 10 mice undergoing the two-step procedure (Fi+OT and Fi/ ASCs+OT groups), an incision was made 14 days after grafting the fibrin Figure 1 Experimental design. Frozen-thawed ovarian tissue samples from 5 different patients were fragmented and distributed equally among the following groups: 5 pieces allocated to non-grafted controls and fixed for analysis; 15 pieces transplanted to SCID mice either in one step (OT group) or two steps (Fi+OT and Fi/ASCs+OT groups). The first step was carried out 14 days before ovarian tissue was grafted in the second step (Day 0). In vivo electron paramagnetic resonance (EPR) oximetry was performed in all grafted groups on Days 3 and 7. After EPR measurements on Day 7, the mice were euthanized and the samples were immediately collected and fixed for histological and immunohistochemical analyses. OT: ovarian tissue, OTT: ovarian tissue transplantation, Fi: fibrin, ASCs: adipose tissue-derived stem cells. implants, in order to fix the ovarian fragments to the site where the fibrin scaffolds had been previously stitched. Once the fibrin implants had been identified, they were gently detached using blunt-tip forceps between the fibrin and peritoneum (Fig. 2C ). Ovarian tissue fragments were then inserted below the remaining fibrin layer (between the peritoneum and detached fibrin) ( Fig. 2D-E) , and 1-2 7/0 Prolene stitches were placed through the fibrin and ovarian tissue to secure the graft, if needed. In the OT group, ovarian fragments were fixed with stitches to the lower third of the parietal peritoneum after scratching the inner peritoneal surface with a scalpel (Luyckx et al., 2014) . The abdominal wall and skin were then closed with 6/0 Prolene.
EPR oximetry
EPR oximetry was duly carried out and oxygen levels were monitored as previously reported (Van Eyck et al., 2009 ) (Supplementary materials and methods). EPR spectra were recorded using an EPR spectrometer (Clin-EPR, Dartmouth EPR Center, Lebanon, NH, USA). In vivo monitoring of pO 2 was performed on post-transplantation Days 3 and 7.
Histological and immunohistochemical staining
Histological analyses were performed on frozen-thawed grafted and nongrafted tissues. All ovarian tissue samples were fixed in 4% formaldehyde, embedded in paraffin and serially sectioned (5-μm-thick sections). Every fifth slide was stained with hematoxylin and eosin (HE) (Merck, Germany), while all the rest were used for immunolabeling. Three slides per graft were stained with Masson's trichrome to evaluate the percentage of fibrotic surface area in grafts. All the slides were digitized after staining and immunolabeling by automated whole-slide image capture using the Pannoramic P250 Flash III scanner (3DHISTECH, Hungary). Image files were analyzed with CaseViewer (3DHISTECH) or ImageJ (http://rsb.info. nih.gov/ij/) software.
Graft vascularization
Vessels of both murine and human origin were investigated by double CD34 immunolabeling, staining endothelial cell membranes, as described in an earlier publication (Supplementary materials and methods). Four sections per graft were analyzed. Vessel sections were considered positive when at least one endothelial cell showed staining. Results are expressed as surface area covered with vessels or endothelial area relative to total section area.
Follicle outcomes
Follicle density was determined as the number of total and/or primordial follicles per mm 3 by counting ovarian follicles in 20 random sections per sample, taking into account section thickness. Surface and volume measurements on HE-stained slides were evaluated using CaseViewer. Only morphologically normal follicles were taken into consideration (Anderson et al., 2014) . Follicle atresia was assessed using morphological parameters in HE-stained slides as previously described (Gougeon, 1986) . Follicle survival rates were calculated as a percentage, comparing non-grafted control tissue follicle counts (considered as 100%) with those in each corresponding grafted piece (Baird et al., 1999) . Follicles were further classified according to stage into primordial or growing (Gougeon, 1986; Dolmans et al., 2007) , and the percentage of each stage was established.
Primordial follicle growth
Three slides per graft were subjected to anti-human Ki-67 immunohistochemical staining, as previously described (Luyckx et al., 2013) . Antibodies used were mouse anti-human Ki-67 (1/100, clone MIB, mAb ref.: M7240, Dako, Belgium), followed by Envision goat anti-mouse IgG (1:2 dilution, Dako). Primordial follicles were classified into two categories: resting, when all granulosa cells (GCs) negative for Ki-67; or growing, with at least one GC positive for Ki-67.
Follicle apoptosis
Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assays were performed to detect DNA fragmentation using the In Situ Cell Death Detection Kit, TMR red (Roche, Belgium). The complete protocol can be found in an earlier study . Slides were first digitized, as described above. For analysis, follicles were identified in consecutive HE-stained sections and TUNEL-positive GCs were counted in each follicle. Follicles were classified as apoptotic when at least one GC was TUNEL-positive. Results are presented as the percentage of apoptotic follicles relative to total follicle count per section.
Statistical analysis
Results are presented as means ± SEM. GraphPad Prism, version 7.00 for Windows, (GraphPad Software, USA) was used for statistical analyses. One or two-way ANOVA was carried out after normality tests, followed by Tukey's or Fisher's LSD multiple comparisons where appropriate. A P value <0.5 was considered statistically significant. Linear regression was performed to correlate endothelial area with follicle survival rates.
Results
EPR oximetry
On Days 3 and 7, pO 2 levels were assessed in all grafted mice (n = 15), but two were excluded from the analysis. In one mouse, negative controls after euthanasia on Day 7 were not hypoxic, suggesting progressive loss of responsiveness of LiPc to pO 2 , while in the other, no LiPc signal was detected due to disruption of the crystals inside the tissue, confirmed by macroscopic assessment of the recovered sample. In all groups, pO 2 levels increased significantly from Days 3 to 7 (P < 0.001). Values on Day 3 were all hypoxic and no significant difference was encountered between groups. However, a significantly higher pO 2 level was observed in the Fi/ASCs+OT group compared to the OT group on Day 7 (P = 0.028), but no significant difference was found between the Fi+OT and OT groups at this time (P = 0.079) (Fig. 3) .
Macroscopic, histological and immunohistochemical evaluation
Macroscopic and histological evaluation
The graft recovery rate was 100%. On post-grafting Day 7, all recovered ovarian tissue fragments were found to be adherent to the peritoneum, but grafts from the OT group had a visibly more whitish appearance than grafts from the Fi+OT and Fi/ASCs+OT groups. There was no difference in fibrotic surface area between groups ( Fig. 4E and Supplementary Fig. S1 ). The volume of recovered grafts did not show any significant difference between groups 7 days after grafting either (P = 0.7698) (Supplementary Table S1 ).
Graft vascularization
Human and murine CD34-positive vessels (Fig. 4B ) evaluated by endothelial area on Day 7 were significantly more extensive in the Fi/ASCs+OT group (mean ± SEM: 8.40 ± 1.16) than in any other group: non-grafted group: 2.35 ± 0.54 (P = 0.0014); OT group: 3.78 ± 1.03 (P = 0.013); and Fi+OT group: 4.03 ± 0.81 (P = 0.018) (Fig. 5A) .
Concerning the area covered with human CD34-positive vessels on Day 7, a significantly greater endothelial surface area was observed in the Fi/ASCs+OT group (6.28 ± 1.15) than in the non-grafted (2.35 ± 0.54 [P = 0.0081]), OT (3.081 ± 0.93 [P = 0.0254]) or Fi+OT (3.15 ± 0.93 [P = 0.0284]) groups (Fig. 5B) . However, as regards murine CD34-positive endothelial area rates, although twice as high in the Fi/ ASCs+OT group (2.11 ± 0.68) compared to the Fi+OT (0.87 ± 0.16) and OT (0.70 ± 0.26) groups, the difference was only significant in relation to the OT group [P = 0.0415] (Supplementary Fig. S2 ).
Follicle outcomes
Follicle density and counts were analyzed in HE-stained sections (Fig. 4A , Table I and Supplementary Table S1 ). There was a significant decrease in total and primordial follicle counts between non-grafted controls and the OT (total: P = 0.0051, primordial: P = 0.0032) and Fi+OT (total: P = 0.0052, primordial: P = 0.0038) groups (Table I) . Follicle densities revealed similar results (vs OT total: P = 0.0084, primordial: P = 0.0055; vs Fi+OT total: P = 0.0094 and primordial: P = 0.00698). On the other hand, no significant difference was observed in total or primordial follicle counts and densities between non-grafted controls and the Fi/ASCs+OT group ( Fig. 5C and D) . Follicle densities per patient are illustrated in Fig. 5E .
Primordial follicle survival rates in terms of follicle counts (as a percentage of controls) were significantly higher in the Fi/ASCs+OT group (61.7 ± 14.12) than in the OT (24.6 ± 4.80, P = 0.0170) or Fi+OT (33.24 ± 6.87, P = 0.0055) groups. Similar results were obtained in a comparison of total follicle counts (Table I ). meters of mercury (mmHg) (mean ± SEM, n = 13 in study, n = 3-5 per group, two-way ANOVA and Tukey's post-hoc test). Levels increased significantly from Days 3 to 7 in all groups (*P < 0.05, **P < 0.01, ***P < 0.001). Significantly higher pO 2 values were obtained in the Fi/ASCs+OT group on Day 7 ( a≠b P = 0.028). A significant positive correlation was found between follicle survival rates and total CD34-positive endothelial area (r = 0.6516, P = 0.0116) (Supplementary Fig. S3 ).
In terms of follicle stage, a significant decrease was detected in the percentage of primordial follicles in the OT and Fi+OT groups compared to non-grafted tissue controls, and a significant concomitant increase in the . P-value references: ns: non-significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
percentage of growing follicles in the OT and Fi+OT groups (vs OT: P = 0.0155, vs Fi+OT: P = 0.0348). By contrast, no significant difference was found in the percentage of primordial or growing follicles in the Fi/ASCs+OT group compared to non-grafted controls (Fig. 5F ).
Follicle growth
There was a significant increase in the percentage of Ki-67-positive primordial follicles (Fig. 4C ) in all groups after grafting (non-grafted controls: 1.61 ± 0.78 vs the OT group: 58.7 ± 15.54 [P = 0.0018], vs the Fi+OT group: 74.97 ± 7.67 [P = 0.0004], vs Fi/ASCs+OT group: 62.67 ± 3.127 [P = 0.0012]) (Fig. 5G) .
Follicle apoptosis
Compared to non-grafted controls (5.41 ± 3.06), the percentage of apoptotic follicles revealed by TUNEL assay (Fig. 4D) showed a significant increase in all groups (OT: 62.23 ± 11.89 [P < 0.0001], Fi+OT: 53.33 ± 3.47 [P = 0.0002], Fi/ASCs+OT: 29.94 ± 3.04 [P = 0.0214]). However, significantly fewer apoptotic follicles were detected in the Fi/ASCs+OT group than in the OT and Fi+OT groups (P = 0.0045 and P = 0.0268, respectively), while no significant difference was found between the OT and Fi+OT groups (P = 0.3561) (Fig. 5H) .
Discussion
ASCs, first described by Zuk et al. in 2002 , are isolated from human lipoaspirates and constitute a population of MSCs with multiple lineage differentiation capacities (Zuk et al., 2001 (Zuk et al., , 2002 . Thanks to easy harvesting using minimally invasive procedures as well as high cellular density, their use in regenerative medicine has been spreading. Indeed, numerous clinical trials (phases I-II and III) assessing ASC safety and efficacy are currently being conducted or have already been completed (https://clinicaltrials.gov), testifying to the growing interest in the potential of these cells in a number of fields (Lee et al., 2013; Garimella et al., 2015; Staff et al., 2016) . The angiogenic potential of ASCs has been investigated in various studies, confirming their capacity to boost angiogenesis by secreting growth factors and differentiating into functional blood vessels (Moon et al., 2006; Schubert et al., 2011; Lafosse et al., 2015) .
One of the major challenges in ovarian tissue transplantation over the past decade has been to increase the lifespan and quality of grafted tissue in order to offer the chance of improved pregnancy outcomes to cancer survivors wishing to conceive. To better address this issue, we developed a two-step grafting procedure involving preparation of the transplantation site with ASCs delivered inside a fibrin implant two weeks before the transplantation itself, as we have achieved better vascularization in the grafting site (Manavella et al., 2018) . In the present study, we investigated the effects of this novel ovarian tissue transplantation approach on vascularization and follicle survival.
Graft pO 2 levels
Grafted ovarian tissue oxygenation was evaluated using in vivo EPR oximetry, a technique that allows repeated measurement of pO 2 levels in target tissues. Our results show an early period of hypoxia in all grafted tissue, regardless of transplantation procedure, followed by significantly increased oxygenation in grafts from Days 3 to 7, consistent with previous observations (Van Eyck et al., 2009) . However, grafts from the Fi/ASCs+OT group showed significantly higher mean pO 2 values (25.6 mmHg) overall on Day 7, reaching oxygenation levels as high as other vascularized intra-abdominal organs, such as the liver (mean: 23.4 mmHg) (Jiang et al., 1996) and renal cortex (mean: 22.5 mmHg) (James et al., 1996) . As the main period of hypoxia persists for the first 5 days post-transplantation (Van Eyck et al., 2009 ) and functional vessels start to appear from Day 7 (Israely et al., 2004; Van Eyck et al., 2010) , our results suggest an active role played by ASCs in the vascularization process of ovarian tissue grafts already between Days 3 and 7 post-grafting. We hypothesize that since ASCs experience hypoxic preconditioning during the first step of transplantation, once the tissue is grafted after 14 days, these cells might already be prone to proangiogenic behavior (Rehman et al., 2004) .
Graft vascularization
Immunolabeling of the human and murine CD34 antigen, analyzed on Day 7, showed a significantly higher vascularized area in the Fi/ASCs +OT group, consistent with the oxygenation kinetics observed with EPR oximetry. Differences found in the present study may be due to the fact that MSCs and many progenitor cell populations are known to promote and stimulate angiogenesis by secretion of proangiogenic factors such as VEGF, hepatocyte growth factor (HGF) and its receptor c-Met, platelet-derived growth factor and basic fibroblast growth factor (Rehman et al., 2004; Sadat et al., 2007; Rubina et al., 2009) , and others like angiogenin (Zhang et al., 2017) , proving their active involvement in angiogenesis. In addition to their paracrine effects MSCs have been shown to aid neovascularization by transdifferentiating Moon et al., 2006; Au et al., 2008) pericytes, thus providing the necessary cellular components to stabilize newly formed vessels. (Au et al., 2008; Mendel et al., 2013) . According to our observations on both graft oxygenation and vascularization, the angiogenic behavior of ASCs in our study appears to boost graft vascularization sooner than in ovarian tissue grafted without these cells.
Follicle survival
Our two-step approach using ASCs was found to yield higher primordial follicle survival rates 7 days after transplantation, reaching a mean of 62%. On the other hand, the standard one-step grafting procedure applied in clinical practice resulted in an expected 25% mean survival rate, in line with the literature (Baird et al., 1999; Nisolle et al., 2000) . The reduced follicle loss and the differences evidenced in this study using our novel two-step ovarian tissue transplantation procedure may be partly explained by the early and concomitant increase in oxygenation and vascularization observed in the group transplanted with the addition of ASCs. Indeed, a strong positive correlation was observed between follicle survival rates and CD34-positive endothelial area in grafts, confirming the positive impact of an early vascularization boost on follicle survival rates in grafted ovarian tissue (Xia et al., 2015) .
Follicle apoptosis
Although apoptosis rates increased in all grafted tissue compared to non-grafted controls, a significantly lower follicle apoptosis rate was found in the Fi/ASCs+OT group compared to both the OT and Fi+OT groups. Differences observed in our study may be explained by the antiapoptotic properties of MSCs acting via paracrine secretion of insulin growth factor 1, interleukin-6, VEGF-A, HGF and transforming growth factor β and by suppression of expression of inflammatory cytokines like tumor necrosis factor α and BCL-2 modifying factor (Santos Nascimento et al., 2014; Song et al., 2017) . Another plausible explanation for the observed decrease in apoptosis could be earlier resumption of the O 2 supply to the graft in the Fi/ASCs+OT group, as evidenced by our EPR measurements, which may have resulted in less severe hypoxic damage. Rates of follicle atresia appeared to be lower in the Fi/ASCs+OT group than with the standard one-step approach, but we believe the difference between follicle atresia and apoptosis may be due to the method used to evaluate each. Indeed, follicle atresia was assessed using morphological parameters in HE-stained sections, which include both early and late signs of apoptosis, while TUNEL assays detect only extensive DNA degradation during the later stages of apoptosis.
Follicle growth
Percentages and numbers of primordial follicles in grafted ovarian tissue fell significantly in both the OT and Fi+OT groups, consistent with observations from previous studies (Baird et al., 1999; Nisolle et al., 2000; Dolmans et al., 2007) . Follicle activation has already been described as one of the causes of primordial follicle depletion in grafted ovarian tissue (Dolmans et al., 2007; Gavish et al., 2018) . Moreover, results obtained with Ki-67 showed a significant increase in primordial follicle growth in all grafted tissue, which could to some extent explain the decrease in numbers of primordial follicles as they develop into growing follicles in the early post-grafting period (Gavish et al., 2018) . On the other hand, the resting follicle pool in the Fi/ASCs+OT group was better preserved than in the other groups, suggesting a decrease in follicle activation that may be due to shortened exposure to hypoxia, decreasing hypoxia-dependent Akt pathway activation in GCs.
ASC-based therapies do indeed show great promise in regenerative medicine, but the specific mechanisms underlying the described beneficial effects remain to be elucidated. Although cells utilized in the present study were commercially acquired, clinical application would require use of autologous ASCs.
Admittedly, the heterogeneous follicle distribution encountered within and between small ovarian cortex samples represents a limitation in studies carried-out on human ovarian tissue Schmidt et al., 2003) , but our findings are encouraging. Our results clearly suggest that the proposed transplantation procedure using ASCs is a promising step towards potentially solving the problem of massive follicle loss after ovarian tissue grafting.
In conclusion, we were able to demonstrate higher rates of oxygenation and vascularization of ovarian tissue in the early post-grafting period, which correlate with increased follicle survival and reduced apoptosis. Future studies should focus on elucidating the mechanisms of action of ASCs in the context of ovarian tissue transplantation, with a view to clinical implementation.
Supplementary data
Supplementary data are available at Human Reproduction online.
